Paragon 28, Inc. (FNA)

USD 10.04

(-3.09%)

EBITDA Summary of Paragon 28, Inc.

  • Paragon 28, Inc.'s latest annual EBITDA in 2023 was -36.61 Million USD , up 3.4% from previous year.
  • Paragon 28, Inc.'s latest quarterly EBITDA in 2024 Q2 was -6.15 Million USD , up 41.8% from previous quarter.
  • Paragon 28, Inc. reported an annual EBITDA of -47.85 Million USD in 2022, down -879.7% from previous year.
  • Paragon 28, Inc. reported an annual EBITDA of -2.3 Million USD in 2021, down -119.15% from previous year.
  • Paragon 28, Inc. reported a quarterly EBITDA of -8.13 Million USD for 2024 Q1, down -64.59% from previous quarter.
  • Paragon 28, Inc. reported a quarterly EBITDA of -3.13 Million USD for 2023 Q3, up 68.12% from previous quarter.

Annual EBITDA Chart of Paragon 28, Inc. (2023 - 2019)

Historical Annual EBITDA of Paragon 28, Inc. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 -36.61 Million USD 3.4%
2022 -47.85 Million USD -879.7%
2021 -2.3 Million USD -119.15%
2020 12.01 Million USD 76.11%
2019 6.82 Million USD 0.0%

Peer EBITDA Comparison of Paragon 28, Inc.

Name EBITDA EBITDA Difference
Abbott Laboratories 10.46 Billion USD 100.35%
Allurion Technologies Inc. -69.03 Million USD 46.96%
Artivion, Inc. 38.14 Million USD 195.994%
Avanos Medical, Inc. 53.2 Million USD 168.823%
Butterfly Network, Inc. -124.84 Million USD 70.672%
Butterfly Network, Inc. -124.84 Million USD 70.672%
Bio-Rad Laboratories, Inc. -608.26 Million USD 93.981%
Boston Scientific Corporation 3.45 Billion USD 101.06%
Perspective Therapeutics, Inc. -14.83 Million USD -146.758%
CONMED Corporation 182.18 Million USD 120.097%
Edwards Lifesciences Corporation 1.76 Billion USD 102.071%
Glaukos Corporation -82.11 Million USD 55.412%
Globus Medical, Inc. 418.23 Million USD 108.754%
Inspire Medical Systems, Inc. -17.06 Million USD -114.619%
Integer Holdings Corporation 282.05 Million USD 112.981%
Medtronic plc 9.05 Billion USD 100.404%
Nevro Corp. -78.31 Million USD 53.245%
Owlet, Inc. -27.48 Million USD -33.195%
Penumbra, Inc. 111.99 Million USD 132.692%
Vicarious Surgical Inc. -69.19 Million USD 47.083%
Smith & Nephew plc 979 Million USD 103.74%
Sonendo, Inc. -54.76 Million USD 33.147%
STERIS plc 1.41 Billion USD 102.592%
Stryker Corporation 5.16 Billion USD 100.71%
Vapotherm, Inc. -34.35 Million USD -6.569%
Zimmer Biomet Holdings, Inc. 2.44 Billion USD 101.495%